Clinical Trials Browser

Phase 1/2 × Central Nervous System Neoplasms × Pharmaceutical Preparations × Clear all

NCT06208657 2026-01-28

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

Phase 1/2 Recruiting

Lymphoma, Neoplasms, Recurrence, Central Nervous System Neoplasms